Investors
Accuitive Medical Ventures
Accuitive Medical Ventures is a venture capital firm with committed capital of $230 million. A market-driven firm looking for revolutionary medical technology investment opportunities, Accuitive specializes in venture financing for companies with outstanding technology and teams. The firm has established relationships with some of the industry’s leading institutions to offer emerging companies and investors the opportunity to build unique new businesses and long-term shareholder value. Accuitive’s connections to some of the industry’s leading practitioners and thought leaders enable them to add substantial value as investors and board members. The firm has offices in Palo Alto, CA, Atlanta, GA and Amelia Island, FL.
Emergent Medical Partners
Emergent Medical Partners is a life sciences investment firm lead by Dr. Thomas Fogarty that focuses on seed and early stage investments. Emergent's partners have more than a half century of combined experience in life sciences investing. Founded in 2007, Emergent has invested in over 15 companies, to date.
Investor Growth Capital
Investor Growth Capital is the wholly owned venture capital arm of Investor AB, a $20 billion publicly traded investment holding company with almost a century of experience financing and developing new healthcare and technology businesses. IGC has achieved notable success in diabetes related investments including MiniMed - a manufacturer of insulin pumps and blood glucose monitors, which was purchased by Medtronic. The company also invested in Amira - a blood glucose monitoring company ultimately acquired by Roche. Other significant healthcare investments include Intuitive Surgical and Kyphon.
Thomas, McNerney & Partners
Specializing in healthcare with $600 million currently under management. The firm has a highly successful investment track record with 52 companies in their portfolio of which 29 have become public companies or been acquired. The firm's investment highlights include AppTec Laboratory Services and Coley Pharmaceuticals.
U.S. Venture Partners
Has invested $1.8 billion in more than 350 companies resulting in over 70 IPOs and numerous, high profile mergers. The company's investments include such well-known entities as Sun Microsystems and Ask Jeeves. Another success was Advanced Cardiovascular Systems, which was later spun off as Guidant Corporation. USVP has also invested in numerous medical device companies that have had positive acquisition outcomes such as Ensure Medical, a cutting edge vascular device manufacturer bought by J&J.
Venrock
Venrock is a premier venture capital firm with offices in Palo Alto, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues the eight-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $2.4 billion in 437 companies resulting in 124 IPOs over the past 40 years, Venrock’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy, portfolio companies have included Adify, Adnexus Therapeutics, Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu.
Versant Ventures
Versant is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm currently manages over $1.6 billion in committed capital and has over 75 companies in its portfolio. Versant is also actively involved in the diabetes sector as an investor in Insulet - a manufacturer of insulin pumps that launched an IPO in May of 2007.
